HANYS Benefit Services' Carol A. Idone Receives Prestigious SPARK Advisor Award

Vice President, Client Relationship Management and Consulting,

Honored for Leadership in "Plan Design & Administration Innovation"

HANYS Benefit Services (HBS) is pleased to announce that Carol A. Idone, CFP®, AIF®, Vice President, Client Relationship Management and Consulting, is the recipient of the 2017 SPARK Advisor Award: Plan Design & Administration Innovation.

This award is presented annually by The SPARK Institute, Inc., to a retirement plan advisor in the United States who "demonstrates leadership in designing plans and administrative processes that improve participant outcomes while managing plan costs." The SPARK Institute helps to shape national retirement policy by providing research, education, testimony, and comments on pending legislative and regulatory issues to members of Congress and relevant government agency officials. Its members serve approximately 85 million participants in 401(k) and other defined contribution plans.

Ms. Idone brings more than 20 years of experience in the financial services and retirement planning field to HBS. She has particular expertise in working with healthcare-focused and not-for-profit organizations. Prior to joining HBS in 2013, Ms. Idone worked at The Hartford and AIG Valic. She previously served as Chief Financial Officer and Senior Vice President of Finance at Seton Health System in Troy, New York, and as a Certified Public Accountant at KPMG in Albany, New York.

"My background has allowed me to see these plans from every angle, and the advising done at HBS is unique in part because of that technical expertise," Ms. Idone said. "I truly enjoy having the opportunity to help our clients develop the plans that will serve their employees most successfully, and I thank The SPARK Institute for this recognition."

"Carol is an extremely dedicated professional and so deserving of this recognition," said James J. Kelley, President, HBS. "Our clients benefit from her expertise and skill in producing unique analysis and reports in various areas, but especially benefit from her plan design modeling.”

HANYS President Bea Grause echoed Mr. Kelley's sentiments. "Carol's expertise is invaluable to our members. We are grateful for her leadership and her commitment to HBS' member-focused philosophy."

Ms. Idone’s expertise can be found in her whitepapers on participant outcomes, and she has been quoted by industry-leading publications.

If you have any questions, please contact Carol directly via our website, or by calling (800) 388-1963.

SECURE 2.0 Discussion Series: Session Two

The retirement industry has been buzzing since the SECURE 2.0 Act was signed into law last December. This new, comprehensive legislation has sparked a lot of discussion. As with any major reform, it will take time for the industry to fully adapt and understand all its implications. Following our April 11 webinar on the first three months of the industry’s response, our team reconvened to discuss some of what we have heard from our client and vendor partners and to respond to some of the great questions we heard from attendees. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. The Discussion SB – Throughout the webinar, I wanted to stress two things: 1) confusion about where to start and what is expected from plan sponsors is normal; and 2) even more than three months in, this is a developing situation and people should expect changes as time goes on. With those in mind, engagement through

SECURE 2.0 Discussion Series: Session One

SECURE 2.0 provisions: What we know and what’s still up in the air The SECURE 2.0 Act, signed into law in late December 2022, has factored heavily in retirement industry discourse since the final legislation was published. As with any legislation of this depth and breadth, there’s a lot to digest and the industry takes time to adjust. Our team of experienced advisors recently met to discuss some of the more nuanced provisions of the legislation, such as changes to Roth contributions, and what they could mean for plan sponsors. Panel participants included the following HBS team members: Noah Buck, Christina Bauer-Dobias, Sean Bayne, Vincent Bocchinfuso and Kathleen Coonan. Highlights of our panel’s conversation below should serve to help guide plan sponsor thinking. On Roth employer contributions NB – In addition to deferring pre-tax or Roth, plan sponsors can now allow employer contributions to be classified as Roth, is that right? VB – Correct. This is immediately available to plan s

What you should know about biosimilars

Rapidly increasing healthcare costs will likely continue to impact employers for the foreseeable future. As a result, many employers are considering strategies to manage these costs, including rising prescription drug costs. The introduction of biosimilar drugs as an alternative to biologics may bring value to healthcare by offering cost savings and increasing employee access to necessary medications. While biosimilars can potentially combat rising prescription drug costs, employers will need to learn more about them before considering how their health plans can accommodate these newer drugs. This article explores biosimilar drugs and ways employers can promote or manage their use. What are biosimilars? The European Medicines Agency defines a biosimilar as “a biological medicine highly similar to another already approved biological medicine.” It is produced from living organisms — humans, animals or microorganisms, meaning they aren’t created from synthesized chemicals. They are also

HANYS Benefit Services

Search This Blog